Tag Archives: VICL

Monday’s Midday Stock Update: Samsung Electronics (SSNLF), ImmunoCellular Therapeutics (IMUC), Anthera Pharmaceuticals (ANTH), Mallinckrodt (MNK), Vical Inc (VICL)

So far Monday, September 2, NASDAQ is down -2.4% and the S&P is down -1.77%. Here are this morning’s most active stocks: Samsung Electronics (SSNLF – Research Report), ImmunoCellular Therapeutics (IMUC – Research Report), Anthera Pharmaceuticals (ANTH – Research Report),

Sunday’s Midday Movers: Samsung Electronics (SSNLF), ImmunoCellular Therapeutics (IMUC), Anthera Pharmaceuticals (ANTH), Mallinckrodt (MNK), Vical Inc (VICL)

So far Sunday, September 1, NASDAQ is down -2.4% and the S&P is down -1.77%. Here are this morning’s most active stocks: Samsung Electronics (SSNLF – Research Report), ImmunoCellular Therapeutics (IMUC – Research Report), Anthera Pharmaceuticals (ANTH – Research Report),

Saturday’s Midday Movers: Samsung Electronics (SSNLF), ImmunoCellular Therapeutics (IMUC), Anthera Pharmaceuticals (ANTH), Mallinckrodt (MNK), Vical Inc (VICL)

So far Saturday, August 31, NASDAQ is down -2.4% and the S&P is down -1.77%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Samsung Electronics (SSNLF – Research Report), ImmunoCellular Therapeutics (IMUC –

Monday’s Midday Movers: American Green Inc (ERBB), NovaBay Pharma (NBY), Anthera Pharmaceuticals (ANTH), Vical Inc (VICL), Celldex (CLDX)

So far Monday, June 3, NASDAQ is down -3.75% and the S&P is down -0.69%. Here are this morning’s most active stocks: American Green Inc (ERBB – Research Report), NovaBay Pharma (NBY – Research Report), Anthera Pharmaceuticals (ANTH – Research

Vical Inc (VICL) was Downgraded to a Hold Rating at H.C. Wainwright

H.C. Wainwright analyst Ram Selvaraju downgraded Vical Inc (VICL – Research Report) to Hold today. The company’s shares closed on Friday at $1.05. According to TipRanks.com, Selvaraju ‘s ranking currently consits of no stars on a 0-5 ranking scale, with

Vical Inc Receives a Buy from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Vical Inc (NASDAQ: VICL), with a price target of $3.50. The company’s shares closed yesterday at $1.22, close to its 52-week low of $1.02. According